Development of a carrier-free dry powder ofloxacin formulation with enhanced aerosolization properties.
Sign Up to like & getrecommendations! Published in 2020 at "Journal of pharmaceutical sciences"
DOI: 10.1016/j.xphs.2020.05.027
Abstract: Tuberculosis (TB) is a serious infectious disease that affects more than new 10 million patients each year. Many of these cases are resistant to first-line drugs so second-line ones, like fluoroquinolones, need to be incorporated… read more here.
Keywords: carrier free; formulation; ofloxacin; free dry ... See more keywords
Biologics Development and Carrier Innovation.
Sign Up to like & getrecommendations! Published in 2017 at "Spine"
DOI: 10.1097/brs.0000000000002023
Abstract: ost bone graft substitutes currently used in M surgery can be broadly categorized into calcium and demineralized bone matrix-based technologies that were developed several decades ago. We have investigated the safety and efficacy of a… read more here.
Keywords: biologics development; autologous bone; bone; carrier ... See more keywords
Rational Development of a Carrier-Free Dry Powder Inhalation Formulation for Respiratory Viral Infections via Quality by Design: A Drug-Drug Cocrystal of Favipiravir and Theophylline
Sign Up to like & getrecommendations! Published in 2022 at "Pharmaceutics"
DOI: 10.3390/pharmaceutics14020300
Abstract: Formulating pharmaceutical cocrystals as inhalable dosage forms represents a unique niche in effective management of respiratory infections. Favipiravir, a broad-spectrum antiviral drug with potential pharmacological activity against SARS-CoV-2, exhibits a low aqueous solubility. An ultra-high… read more here.
Keywords: formulation; powder; carrier free; drug ... See more keywords